Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

por Eisen, T, Boshoff, C, Mak, I, Sapunar, F, Vaughan, M M, Pyle, L, Johnston, S R D, Ahern, R, Smith, I E, Gore, M E
Publicado 2000